|
|
Volumn 24, Issue 1, 2007, Pages 71-75
|
|
A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer
a
|
|
Author keywords
5 DFUR; Chemotherapy; Docetaxcel; Gastric cancer; Second line chemotherapy; Taxan
|
|
Indexed keywords
DOCETAXEL;
DOXIFLURIDINE;
ANTINEOPLASTIC AGENT;
FLOXURIDINE;
TAXOID;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANOREXIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
FATIGUE;
FEMALE;
HUMAN;
LEUKOPENIA;
MALE;
NAUSEA;
NEUTROPENIA;
PILOT STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STOMACH CANCER;
STOMATITIS;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
MIDDLE AGED;
PROGNOSIS;
STOMACH TUMOR;
SURVIVAL RATE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FEMALE;
FLOXURIDINE;
HUMANS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PROGNOSIS;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TAXOIDS;
|
|
EID: 34548739505
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02685905 Document Type: Article |
|
Times cited : (14)
|
|
References (8)
|
